During the past decade, Northwell Health Neuroscience Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Northwell Health Neuroscience Institute" are "Immune Mediated Necrotizing Myopathy" (1 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "Northwell Health Neuroscience Institute" in a lesser frequency.

Most popular intervention types in "Northwell Health Neuroscience Institute" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deep Brain Stimulation (DBS)" (1 trials), "Placebo" (1 trials) and "zilucoplan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwell Health Neuroscience Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Northwell Health Neuroscience Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Northwell Health Neuroscience Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwell Health Neuroscience Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".